Alerts will be sent to your verified email
Verify Email
VAISHALI
|
Vaishali Pharma
|
Bal Pharma
|
Tyche Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.83 % | 8.41 % | 12.13 % |
|
5yr average Equity Multiplier
|
2.48 | 4.51 | 1.16 |
|
5yr Average Asset Turnover Ratio
|
0.88 | 1.01 | 0.53 |
|
5yr Avg Net Profit Margin
|
3.68 % | 1.86 % | 19.18 % |
|
Price to Book
|
1.8 | 1.51 | 0.84 |
|
P/E
|
0.0 | 17.28 | 12.28 |
|
5yr Avg Cash Conversion Cycle
|
87.63 Days | 27.6 Days | 111.78 Days |
|
Inventory Days
|
6.87 Days | 99.82 Days | 69.03 Days |
|
Days Receivable
|
177.19 Days | 115.65 Days | 101.01 Days |
|
Days Payable
|
159.49 Days | 154.91 Days | 90.14 Days |
|
5yr Average Interest Coverage Ratio
|
2.55 | 1.5 | 2385.83 |
|
5yr Avg ROCE
|
15.65 % | 19.2 % | 16.3 % |
|
5yr Avg Operating Profit Margin
|
5.99 % | 9.12 % | 21.21 % |
|
5 yr average Debt to Equity
|
0.48 | 1.95 | 0.0 |
|
5yr CAGR Net Profit
|
-4.82 % | 8.78 % | -9.09 % |
|
5yr Average Return on Assets
|
3.24 % | 1.88 % | 10.39 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
26.32 % | 50.86 % | 61.97 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.42 % | -1.14 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vaishali Pharma
|
Bal Pharma
|
Tyche Inds
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|